RLAY compared with AMLX: revenue, margins and what each company keeps, and the suppliers and customers both name

RLAYRelay Therapeutics, Inc.

Mkt capRevenueRevenue

AMLXAmylyx Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

RLAYRelay Therapeutics, Inc.

AMLXAmylyx Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 500dMethod ›

Moved together

RLAYwithAMLX

×0.37co-movement · AMLX on RLAY · 500d

r 0.31scale to r 0.75

Shared co-movers3with RLAYwith AMLX

XNCRXencor Incr 0.45r 0.38

IMNMImmunome Inc.r 0.48r 0.37

SYRESpyre Therapeutics, Inc.r 0.38r 0.36

RLAY, solidAMLX, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

RLAYRelay Therapeutics, Inc.

17.43▲+0.87%· post 17.43

Mkt cap$3.8BRevenue$350,000Q2 FY26

AMLXAmylyx Pharmaceuticals, Inc.

29.19▲+4.09%· post 29.19

ClosedNov 3 '26

Mkt cap$3.1BRevenue$416,000Q3 FY24

Compare

ClosedNov 3 '26

RLAYRelay Therapeutics, Inc.

AMLXAmylyx Pharmaceuticals, Inc.

17.43▲+0.87%post 17.43

Price

29.19▲+4.09%post 29.19

$3.8B

Mkt cap

$3.1B

Q2 FY26$350,000

Revenue

$416,000Q3 FY24

RLAY17.43▲+0.87%vsAMLX29.19▲+4.09%ClosedNov 3 '26